The Latest Breaking News from FDA

SACRAMENTO, Calif. — The wife of a Northern California congressman died late last year after ingesting a plant that is generally considered safe and is used as an herbal remedy for a variety of ailments, including diabetes, obesity and high cholesterol, KHN has learned.

The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A (congenital Factor VIII deficiency) in adult patients. BioMarin shares traded as high as 2.28 percent, in a range of $91.39 to $93.68…

Recently, the Federal Trade Commission (FTC) announced that it will send payments to 576 consumers across the country who purchased 'deceptively marketed' cannabidiol (CBD) products from Arizona-based Kushly Industries LLC.

The former TV doctor, who two years ago said "we ought to completely change our policy on marijuana," mocks his opponent for agreeing.

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

Cerevel Therapeutics more than doubled its cash balance to keep pace with Karuna Therapeutics in a head-to-head showdown.

A special House panel looking into the government's coronavirus response says the Trump White House tried to pressure U.S. health experts into reauthorizing the anti-malaria drug hydroxychloroquine that had been discredited as a COVID-19 treatment

The drug developer earned FDA approval for a new depression treatment. Now comes the hard part.

Plus: Twitter whistleblower reports, court says FDA must reconsider vaping products, and more...